Effect Of Delta Sodium on the Postoperative Outcomes in Liver Transplant Recipients
SOLT
Effect of Perioperative Delta Sodium on Outcomes in Liver Transplant Recipients
1 other identifier
observational
342
1 country
1
Brief Summary
We analyzed the association of delta sodium levels with their effect on post liver transplant outcomes in consecutive patients undergoing liver transplantation. Records were analyzed for electrolytes and outcome measures, and data was analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedFirst Submitted
Initial submission to the registry
June 30, 2019
CompletedFirst Posted
Study publicly available on registry
October 2, 2019
CompletedOctober 2, 2019
September 1, 2019
7 years
June 30, 2019
September 29, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
change in serum sodium in liver transplant recipients
difference between baseline and postoperative sodium in liver transplant recipients
1 day
post transplant mortality
post transplant mortality after liver transplantation
1 month
Secondary Outcomes (4)
post operative neurological complications
1 month
duration of mechanical ventilation
1 month
Duration of hospital stay
1 month
Duration of ICU stay
1 month
Study Arms (1)
Liver Transplant Recipients
All elective liver transplant recipients done between study period
Interventions
Eligibility Criteria
Liver transplant recipients more than 18 years in ILBS during study period
You may qualify if:
- All liver transplant recipients between Jan 2011 to Jan 2017
- Records available
You may not qualify if:
- Acute fulminant liver failure
- All patients less than 18 years
- Re operated cases
- Pregnant patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, 110070, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karthik T Ponnappan, DM
Institute of Liver and Biliary Sciences
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant
Study Record Dates
First Submitted
June 30, 2019
First Posted
October 2, 2019
Study Start
January 1, 2011
Primary Completion
December 31, 2017
Study Completion
December 31, 2017
Last Updated
October 2, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share